Drug-resistant pulmonary tuberculosis in western Turkey: Prevalence, clinical characteristics and treatment outcome

Annals of Saudi Medicine

Volumn 25, Issue 4, 2005, Pages 313-318

  Surucuoglu, Suheyla ^a   Ozkutuk, Nuri ^a   Celik, Pinar ^a   Gazi, Horu ^a   Dinc, Gonul ^a   Kurutepe, Semra ^a   Koroglu, Galip ^a,b   Havlucu, Yavuz ^a   Tuncay, Gulgun ^c  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b Manisa Tuberculosis Dispensary   (Turkey)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REGISTER; SEX DIFFERENCE; SPUTUM ANALYSIS; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS CONTROL; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

EID: 24744441950     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2005.313     Document Type: Article

References (20)

1. Murray JF. A century of tuberculosis. Am J Respir Crit Care Med. 2004;169:1181-1186.
2. World Health Organization (WHO). Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 1994-1997. Geneva, Switzerland: WHO, 1997. http;//www.who.int/gtb/publications/dritw/index.htm
3. Tahaoglu K, Kizgin O, Karagoz T, Tor M, Partal M, Sadoglu T. H initial and acquired drug resistance in pulmonary tuberculosis in Turkey. Tuber Lung Dis. 1994;75:324-328.
4. Bengisun S, Karnak D, Palabiyikoglu I, Saygun N. Mycobacterium tuberculosis drug resistance in Turkey, 1976-1997. Scand J Infect Dis. 2000;32:507-510.
5. Balci I, Dikensoy O, Bayram A, Filiz A. Drug resistant tuberculosis at the university hospital in Gaziantep, south-eastern Turkey. J Int Med Res. 2000;28:300-306.
6. Kilicaslan Z, Albal H, Kiyan E, Aydemir N, Seber E. Drug resistance in pulmonary tuberculosis in Istanbul. Eur J Clin Microbiol Infect Dis. 2002;21:763-764.
7. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison PA, Rist NA, Smelev NA. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bulletin of the World Health Organization. 1969;4:21-43.
8. Siddiqi SH. Drug susceptibility testing. In: BACTEC TB system product and procedure manual (Revision E). Maryland: Becton Dickinson, 1996: IV.1-IV.23.
9. Guidelines for surveillance of drug resistance in tuberculosis. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance, Second Edition, WHO, Geneva, 2003. WHO/TB/2003.320-WHO/CDS/CSR/RMD/2003.3.
10. WHO. Global Tuberculosis Control. Surveillance, Planning, Financing. Communicable Diseases, World Health Organization, Geneva: 2002. WHO/CDC/STB/2001.11.
11. Goral G, Aydin O, Ekici M. Acquired drug resistance in Mycobacterium tuberculosis isolates from treated patients in the province of Bursa, Turkey. Clin Microbiol Infect. 1997;3:545-548.
12. Kartaloglu Z, Bozkanat E, Ozturkeri H, Okutan O, Ilvan A. Primary antituberculosis drug resistance at Turkish Military Chest Diseases Hospital in Istanbul. Med Principles Pract. 2002;11:202-205.
13. Kisa O, Albay A, Baylan O, Balkan A, Doganci L. Drug resistance in Mycobacterium tuberculosis: a retrospective study from a 2000-bed teaching hospital in Ankara, Turkey. Int J Antimicrob Agents. 2003;22:456-457.
14. Durmaz R, Ozerol IH, Durmaz B, Gunal S, Senoglu A, Evliyaoglu E. Primary drug resistance and molecular epidemiology of M. tuberculosis isolates from patients in a population with high tuberculosis incidence in Turkey. Microb Drug Resist. 2003;9:361-366.
15. Samman Y, Krayem A, Haidar M, Mimesh S, Osoba A, Al-Mowaallad A, Abdelaziz M, Wali S. Treatment outcome of tuberculosis among Saudi nationals: role of drug resistance and compliance. Clin Microbiol Infect. 2003;9:289-294.
16. Johansson E, Long NH, Diwan VK, Winkvist A. Attitudes to compliance with tuberculosis treatment among women and men in Vietnam. Int J Tuberc Lung Dis. 1999;3:862-868.
17. Guidelines for the management of drug resistant tuberculosis. WHO/TB/96.210 (Rev.1), World Health Organization, 1997.
18. Tsao TCY, Chiou W, Lin H, Wu T, Lin M, Yang P, Tsai Y. Change in demographic picture and increase of drug resistance in pulmonary tuberculosis in a 10-year interval in Taiwan. Infection. 2002;30:75-80.
19. Tocque K, Bellis MA, Beeching NJ, Syed Q, Remmington T, Davies PDO. A case-control study of lifestyle risk factors associated with tuberculosis in Liverpool, North-West England. Eur Respir J. 2001;18:959-964.
20. Tattevin P, Casalino E, Fleury L, Egmann G, Ruel M, Bouvet E. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis. Chest. 1999;115:1248-1253.